Yahoo Web Search

Search results

  1. May 7, 2024 · In their latest study, Gygi and the team wanted to identify signatures associated with severe COVID-19 infection and mortality. Furthermore, they examined interactions of these hallmarks to better ...

  2. 3 days ago · The risk of death among patients hospitalized within 30 days of infection decreased over time but was still significantly elevated 3 years post-infection (incidence rate ratio, 1.29). Although the risk of long COVID declined over that time, substantial residual risk persisted, leading to 90.0 disability-adjusted life years (DALYs) per 1,000 people.

  3. 3 days ago · The bad news: COVID-19 patients who were hospitalized within the first 30 days after infection face a 29% higher risk of death in the third year compared with people who have not had the virus. However, the three-year death risk still marks a significant decline compared with such risk at the one- and two-year marks post-infection.

  4. May 23, 2024 · On February 6, 57-year-old Patricia Dowd of San Jose, California became the first COVID-19 death in the United States discovered by April 2020. She died at home without any known recent foreign travel, after being unusually sick from flu in late January, then recovering, remote working , and suddenly dying on February 6.

  5. May 16, 2024 · The CDC recommends a COVID-19 vaccine for everyone age 6 months and older. The COVID-19 vaccine can lower the risk of death or serious illness caused by COVID-19. COVID-19 medicine helps people who are at risk, diagnosed or who have symptoms of the disease. You can get medicine to manage symptoms.

  6. May 13, 2024 · 47% lower risk of hospitalization for heart failure. Relative to one or no vaccination, COVID-19 vaccination was tied to an 82% lower risk of death from any cause, a 47% lower risk of hospitalization for heart failure, and a 13% reduced risk of infection over 6 months.

  7. May 7, 2024 · Emory University School of Medicine researchers, in partnership with the University of Missouri Kansas City (UMKC), have been awarded a five-year, $6 million award from the Patient-Centered Outcomes Research Institute (PCORI) to conduct a study aimed at improving health outcomes for pregnant Black women. May 22, 2024.